The study aims to further validate the anti-fibrotic and anti-inflammatory activity of CM-101 while providing safety and PK data to...

- Under the terms of the research collaboration and exclusive option agreement, the companies will initiate a gene editing research...

Shares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol "CMMB"...

Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023 Funds Expected to Support the Recently Announced...

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement... Read More